Long-term outcome of percutaneous transhepatic drainage for benign bile duct stenoses

A Eickhoff1, D Schilling, R Jakobs

  • 1Medical Department C, Gastroenterology, Hepatology and Oncology, Klinikum Ludwigshafen, Academic Hospital of the University of Mainz, Germany. eickhofa@klilu.de

Insights

Percutaneous transhepatic stenting effectively treats benign bile duct strictures, offering a safe alternative to surgery. This procedure provides significant relief from jaundice and cholestasis, with good long-term outcomes for many patients.

Area of Science:

  • Gastroenterology
  • Interventional Radiology
  • Hepatology

Background:

  • Benign bile duct stenoses often result from biliary surgery, pancreatic diseases, or sclerosing cholangitis.
  • These strictures pose challenges for gastroenterologists and surgeons, particularly when endoscopic treatment is not feasible.
  • The efficacy of percutaneous transhepatic stenting for these conditions requires further definition.

Purpose of the Study:

  • To evaluate the safety and effectiveness of percutaneous transhepatic stenting for symptomatic benign bile duct strictures.
  • To assess the long-term resolution of strictures and the tolerability of drainage removal after stenting.
  • To define the role of percutaneous transhepatic stenting as a therapeutic option for benign biliary strictures.

Main Methods:

  • A prospective study involving 36 patients with symptomatic benign bile duct stenoses or strictures post-surgery.
  • Patients underwent percutaneous transhepatic stenting.
  • Outcomes assessed included primary success rate, stricture resolution, clinical improvement, and long-term failure rates.

Main Results:

  • The primary success rate of percutaneous transhepatic biliary drainage (PTBD) was 92% (33/36 patients), with all patients showing improvement in jaundice and cholestasis.
  • Complete stricture relief and clinical improvement were achieved in 72% (26/36) of patients after a median stenting duration of 14.5 months.
  • Long-term failures occurred in 27% (10/36) of patients after a median follow-up of 48 months.

Conclusions:

  • Percutaneous transhepatic stenting is a safe and effective method for achieving adequate internal bile drainage in patients with symptomatic benign biliary strictures.
  • The procedure offers both short-term interventional benefits and a viable long-term alternative to surgical intervention.
  • Tolerable complication rates support the use of percutaneous transhepatic stenting for benign biliary strictures.
Abstract